Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-09-11Investigation of the Cylex® ImmuKnow® Assay
-
CLINICAL_TRIALS study record update · 2014-09-10A Phase I Trial of Recombinant Human Interleukin-12 After High-Dose Therapy and Autologous Hematopoietic Stem Cell Support
-
CLINICAL_TRIALS study record update · 2014-09-08A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2014-09-01A Phase II Study of Sunitinib Malate (Sutent®; SU11248) in Patients With Intermediate-2 or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
-
CLINICAL_TRIALS study record update · 2014-08-12A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-08-06Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS
-
CLINICAL_TRIALS study record update · 2014-08-06The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
-
CLINICAL_TRIALS study record update · 2014-08-05Clinical and Biological Predictors of Therapy-Related Leukemia
-
CLINICAL_TRIALS study record update · 2014-07-02Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients With Hematological Diseases
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase II Study of an Oral VEGF Receptor Tyrosine Kinase Inhibitor (PTK787/ZK222584) (IND #66370, NSC #719335) in Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase 4, Open-Label, Single-Arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes.
-
CLINICAL_TRIALS study record update · 2014-06-06The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation
-
CLINICAL_TRIALS study record update · 2014-05-02Non-Myeloablative Allogeneic Bone Marrow Transplant for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-05-02Matched Unrelated and Haploidentical Bone Marrow Transplantation for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-04-28QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME
-
CLINICAL_TRIALS study record update · 2014-04-17Phase III Trial of T Lymphocyte Depletion by Elutriation and CD34 Add-Back for Allogeneic Bone Marrow Transplantation
-
CLINICAL_TRIALS study record update · 2014-04-17Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) After T-Lymphocyte Depleted Allogeneic BMT for Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2014-03-31T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-03-20A Phase I and Phase II Study of the Efficacy and Safety of Maintenance Treatment With Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes Who Achieved Hematological Response to Azacitidine
-
CLINICAL_TRIALS study record update · 2014-03-20A Phase I/II Study of Vorinostat in Combination With Low Dose Ara-C for Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2014-03-19A Phase II Study of Azacitidine (Vidaza®) Combined to Epoetin Beta (NeoRecormon®) in IPSS Low-risk and Intermediate-1 MDS Patients, Resistant to ESA
-
CLINICAL_TRIALS study record update · 2014-03-07Allogeneic Peripheral Blood Stem Cell Transplantation Using a Non-Myeloablative Preparative Regimen for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-03-05A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-03-04An Open Label Randomized Phase II Study of an Appetite Stimulant, Cyproheptadine Hydrochloride, With and Without a Nutritional Supplement, in Children With Cancer/Treatment-Related Weight Loss
-
CLINICAL_TRIALS study record update · 2014-02-20A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia